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Stress increases the risk of drug abuse, causes relapse to drug seeking, and potentiates
the rewarding properties of both nicotine and cocaine. Understanding the mechanisms
by which stress regulates the rewarding properties of drugs of abuse provides valuable
insight into potential treatments for drug abuse. Prior reports have demonstrated that stress
causes dynorphin release, activating kappa opioid receptors (KOR) in monoamine circuits
resulting in both potentiation and reinstatement of cocaine and nicotine conditioned place
preference. Here we report that kappa opioid-dependent reinstatement of cocaine and
nicotine place preference is reduced when the mice are exposed to a randomized chronic
mild stress (CMS) regime prior to training in a conditioned place preference-reinstatement
paradigm. The CMS schedule involves seven different stressors (removal of nesting for
24 h, 5 min forced swim stress at 15◦C, 8 h food and water deprivation, damp bedding
overnight, white noise, cage tilt, and disrupted home cage lighting) rotated over a 3-week
period.This response is KOR-selective, as CMS does not protect against cocaine or nicotine
drug-primed reinstatement. This protection from reinstatement is also observed following
sub-chronic social defeat stress, where eachmouse is placed in an aggressor mouse home
cage for a period of 20 min over 5 days. In contrast, a single acute stressor resulted
in a potentiation of KOR-induced reinstatement, as previously reported. Prior studies
have shown that stress alters sensitivity to opioids and prior stress can inﬂuence the
pharmacodynamics of the opioid receptor system. Together, these ﬁndings suggest that
exposure to different forms of stress may cause a dysregulation of kappa opioid circuitry
and that changes resulting frommild stress can have protective and adaptive effects against
drug relapse.
Keywords: kappa opioid receptor, cocaine, nicotine, stress, conditioned place preference
INTRODUCTION
It is well-established that stress increases the risk of drug abuse,
relapse to drug seeking, and potentiates the rewarding proper-
ties of cocaine (Covington and Miczek, 2001; McLaughlin et al.,
2003; Redila and Chavkin, 2008; Bruchas et al., 2010). Previous
studies have implicated a critical role for dynorphin/kappa opioid
systems in the mediation of stress-induced behaviors includ-
ing reinstatement of drug seeking in both place preference and
self-administration animalmodels. Studies have shown that stress-
induced reinstatement to alcohol, cocaine, and nicotine seeking
is absent in kappa opioid receptor (KOR) KO and dynorphin
KO mice as well as following pretreatment with KOR antago-
nists (Beardsley et al., 2005; Redila and Chavkin, 2008; Walker
and Koob, 2008; Walker et al., 2011; Jackson et al., 2013). How-
ever, while numerous models of acute stress reinstate drug seeking
through dynorphin/KOR activation, the effects of prior repeated
stress exposure, and various magnitudes of stress exposure on
KOR-mediated reinstatement has not been examined.
The dynorphin/KOR system is composed of prodynorphin
peptides and KOR, a seven-transmembrane spanning Gi/o
protein-coupled receptor (GPCR). In addition to the classical
inhibitor effects on adenylate cyclase activity, KOR also cou-
ples to mitogen-activated protein kinase pathways (Bruchas et al.,
2010; Al-Hasani and Bruchas, 2011) to mediate various behavioral
effects (Bruchas et al., 2011; Potter et al., 2011). It is thought that
stress causes dynorphin release activatingKORwithinmonoamine
nuclei (ventral tegmental area, dorsal raphe, locus coeruleus) and
their projection targets (extended amygdala, nucleus accumbens,
etc.; Wise, 2004; Zhang et al., 2005; Carlezon et al., 2006; Gehrke
et al., 2008; Land et al., 2008, 2009; Ebner et al., 2010; Bruchas
et al., 2011; Al-Hasani et al., 2013; Graziane et al., 2013). The KOR-
mediated reduction in dopamine and serotonin activity results in
dysphoria-like behavior that drives reinstatement of drug seeking
to relieve this negative affective state. KORs are highly regulated
via G-protein-coupled receptor kinase (GRK) phosphorylation
and desensitization mechanisms. In opioid receptors this cellular
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regulatory system acts to remove receptor-G-protein activation,
and promotes tolerance, arrestin signaling and/or receptor recy-
cling (McLaughlin et al., 2004; Al-Hasani and Bruchas, 2011;
Williams et al., 2013).
Chronic mild stress (CMS) is a widely adopted animal model
for inducing depression- and anxiety-like behaviors because
it mimics the unpredictable intermittent stress exposure that
humans experience, for complete review see Hill et al. (2012).
The model utilizes repeated, randomized stress events, over the
course of several weeks to mimic the unpredictable nature of mild
stress experience (Elizalde et al., 2008; Peng et al., 2012; Tye et al.,
2013). Numerous studies have demonstrated that various types
of CMS models act to alter neurotransmitter systems includ-
ing monoamine (dopamine, serotonin, and norepinephrine),
gamma-aminobutyric acid (GABA), and glutamatergic transmis-
sion (Rasheed et al., 2008; Vancassel et al., 2008; Tye et al., 2013).
However, the role of CMS on opioid system regulation is not
as well-known, with only a few reports showing that dynor-
phin and enkephalin opioid neuropeptidemRNAremain relatively
unchanged in CMS models in various brain regions (Bertrand
et al., 1997; Bergström et al., 2008). More recent reports have
shown that repeated stress can dysregulate the effects of KOR
signaling within dorsal raphe serotonergic circuits (Lemos et al.,
2012a) but the functional consequences of repeated stress exposure
or CMS compared to acute and sub-chronic stressors on kappa
opioid-dependent behaviors has not been investigated.
Here we determined how different types of exposure to stress
(acute, sub-chronic, and chronic) impact subsequent kappa
opioid-mediated reinstatement of cocaine and nicotine place pref-
erence. We determined how different forms of stress, including a
3-week CMS, sub-chronic social defeat stress (SDS), and acute
forced swim stress (FSS), impact kappa opioid-induced reinstate-
ment. We found that the initial cocaine and nicotine conditioned
place preference were unchanged in sub-chronic stress and CMS
exposure, however, KOR-induced cocaine and nicotine reinstate-
mentwas absent inmice thatwere pre-exposed toCMS, in contrast
to acute stress, which caused potentiated KOR-reinstatement. In
addition, we found that cocaine and nicotine drug-primed rein-
statement is not affected by pre-exposure to stress, suggesting that
this protective ablation of KOR-induced reinstatement by CMS,
selectively affects KOR-mediated behavioral responses.
MATERIALS AND METHODS
ANIMAL SUBJECTS
Male C57BL/6 wild-type mice, bred locally and maintained in
Washington University mouse facility (20–30 g) were used for all
experiments. All mice were group-housed within the Animal Core
Facility at Washington University in St. Louis, given access to food
pellets and water ad libitum, and maintained in speciﬁc pathogen-
free housing. Mice were transferred at least 1 week before testing
into a colony room adjacent to the behavioral testing room to
acclimatize to the study environment and prevent stress during
conditioning phases. Housing rooms were illuminated on a 12-h
light/dark cycle with lights on at 7AM.All animal procedures were
approved by the Animal Care and Use Committee of Washington
University in St. Louis, in accordance with the National Institutes
of Health Guide for the Care and Use of Laboratory Animals.
DRUGS
Cocaine HCl and racemic U50,488 methanesulfonate were
provided by the National Institute on Drug Abuse and Drug Sup-
ply Program and in some instances Sigma Aldrich (St. Louis, MO,
USA). Nicotine hydrogen tartrate salt was purchased from Sigma
Aldrich (St. Louis, MO, USA), dissolved in phosphate buffered
solution. The free base form of nicotine was used for calculat-
ing all injection doses. All drugs were dissolved in saline unless
otherwise indicated.
CONDITIONED PLACE PREFERENCE AND REINSTATEMENT PARADIGM
Mice were trained in an unbiased, balanced three-compartment
conditioning apparatus and the reinstatement of cocaine place
preference (CPP) paradigmwas conducted as previously described
(Land et al., 2009; Bruchas et al., 2011; Al-Hasani et al., 2013). On
pre-conditioning day mice were allowed free access to all three
chambers for 30 min (cocaine CPP) and 20 min (nicotine CPP).
Time spent in each compartment was recorded with a video cam-
era (ZR90; Canon) and analyzed using Ethovision 8.5 (Noldus).
Mice were randomly assigned to saline and drug compartments
and received a saline injection in the morning (10 ml/kg, s.c.)
and cocaine (15 mg/kg, s.c.) or nicotine (0.5 mg/kg, s.c.; Jack-
son et al., 2013) injection in the afternoon, at least 4 h after the
morning training on two consecutive days for nicotine condition-
ing and three consecutive days for cocaine conditioning. To test
for cocaine place preference the mice were allowed free access to
the three compartments. Scores were calculated by subtracting the
time spent in the drug-paired compartment, post-test minus the
pre-test. Mice were considered to have conditioned if the con-
ditioning score was within 15–85% of total conditioning time,
approximately 50 and 80% of mice reached this criteria for nico-
tine and cocaine conditioning, respectively. This was followed
by 2 days (nicotine) or 3 days (cocaine) of extinction training
during which saline (10 ml/kg, s.c.) was injected in both the
morning and afternoon prior to placement into isolated condi-
tioning compartments. Mice were then tested for extinction of
place preference with free access to all three chambers. Mice were
considered to have extinguished cocaine and nicotine preference
if scores fell within 15% of their initial preference scores, approx-
imately 98% of mice met this criteria. Mice that did not meet
these criteria were excluded from the study and mice that met
these criteria and extinguished continued on to the reinstatement
phase.
On reinstatement test day mice were injected with KOR ago-
nist, U50,488 (5 mg/kg, i.p.), placed in their home cage for 30 min
(cocaine CPP) or 20 min (nicotine CPP) as previously described
(Redila and Chavkin, 2008; Land et al., 2009; Al-Hasani et al.,
2013), after which they were placed in the CPP apparatus and
allowed free access to all three compartments for reinstatement
expression. Reinstatement was measured as time (s) in drug-
paired chamber on reinstatement test day minus time spent in
drug-paired chamber following extinction training. On the fol-
lowing day, all mice were exposed to a priming injection of
cocaine (15 mg/kg, s.c.) or nicotine (0.5 mg/kg, s.c.) to test
for drug-primed reinstatement and placed in the apparatus with
free access to all compartments. Reinstatement scores were cal-
culated by subtracting the time spent in the cocaine or nicotine
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side post-reinstatement minus the extinction test as previously
described (Land et al., 2009; Bruchas et al., 2011).
ACUTE STRESS
During reinstatement (day 10)micewere subjected to FSS inwhich
they were placed in an 18 cm deep bucket of water at 30◦C and
allowed to swim for upto 6 min. Mice were removed immediately
if they appeared to be at risk of drowning. After a 5min dry off and
recovery period mice were injected with U50, 488 (5 mg/kg, i.p.)
in the home cage for 30 min and then placed in the CPP chambers,
with access to all three compartments to access reinstatement to
cocaine place preference.
SUB-CHRONIC SOCIAL DEFEAT STRESS
Social defeat stress was performed as previously described
(Bruchas et al., 2011). From the afternoon of the conditioning
post-test (day 5) until post-extinction day (day 9)micewere placed
in the home cage of an aggressor mouse for a period of 20 min
in the afternoon 2 h following extinction or post-testing (typi-
cally from 4 to 6 PM). Mice were monitored carefully for severe
injury during SDS and were removed if necessary. No mice met
this criterion in this study. In addition, as previously described
(Land et al., 2009; Bruchas et al., 2011) all mice are observed and
tracked to receive similar bouts of aggression and exhibit charac-
teristic social defeat postures (McLaughlin et al., 2006; Land et al.,
2009) to ensure similar stress exposure in each treatment group.
On day 10 mice were injected with U50,488 (5 mg/kg, i.p.) in the
home cage and then placed in the CPP chambers 30 min later
to access reinstatement to cocaine seeking. On day 11, for drug-
primed reinstatement, mice were injected with cocaine (15 mg/kg,
i.p.) and immediately placed in the testing chambers.
CHRONIC MILD STRESS PARADIGM
In order to model randomized mild stress exposure, we adapted
a previously validated CMS paradigm. Stressors were randomly
assigned during the 3-week stress period (outlined in Table 1)
prior to conditioned place preference/reinstatement procedure.
During reinstatement phase the mice were injected with U50,488
(5 mg/kg, i.p.) in the home cage (30 min) and then placed in the
CPP chambers to assess reinstatement to cocaine place preference.
On the following day, mice were injected with cocaine (15 mg/kg,
s.c.) or nicotine (0.5 mg/kg, s.c.) priming injection and again
allowed free access to all three chambers to determine drug prime-
induced reinstatement of place preference.
LOCOMOTOR ACTIVITY
During the 3-day conditioning period and during reinstatement
test days, locomotor activitywas recorded as distance traveled (cm)
throughout the 30 min period using video tracking (Canon) of
animal movement and Ethovision 8.5 software analysis (Noldus).
During the conditioning period the total distance (cm) on condi-
tioning days are represented. During reinstatement post-test trials
distance (cm) is represented as 5 min bins throughout the 30 min
test period.
DATA ANALYSES AND STATISTICS
Data were expressed as means ± SEM. All raw data were calcu-
lated via Ethovision video tracking and then place preference or
locomotor data were calculated as described. Data were normally
distributed, and differences between groups were determined
using Student’s independent t-tests, one-way ANOVA, or two-way
ANOVA as appropriate. ANOVA’s were followed by post hoc Bon-
ferroni comparisons if the main effect was signiﬁcant at p < 0.05.
Statistical analyses were conducted using GraphPad Prism 5.0F
(GraphPad, San Diego, CA, USA).
RESULTS
ACTIVATION OF KAPPA OPIOID RECEPTORS FOLLOWING ACUTE
STRESS POTENTIATES REINSTATEMENT OF COCAINE PLACE
PREFERENCE
It has previously been shown that FSS is sufﬁcient to induce rein-
statement and potentiation to drug seeking in a KOR-dependent
manner (McLaughlin et al., 2003; Schindler et al., 2012; Smith
et al., 2012). Furthermore, stress-induced activation of KOR rein-
states nicotine, alcohol, and cocaine seeking (Bruchas et al., 2010;
Van Bockstaele et al., 2010; Wee and Koob, 2010; Graziane et al.,
2013). In this study, we determined whether acute exposure to a
single swim stress would prevent or potentiate a subsequent KOR-
mediated reinstatement of CPP. Mice were subjected to cocaine
conditioning, extinction, and reinstatement as described. On
reinstatement day mice were exposed to swim stress for up to
6 min, were injected with KOR agonist U50,488 (5 mg/kg, i.p)
5 min following recovery, and then placed in the CPP cham-
ber 30 min later (Figure 1A). Mice subjected to FSS prior to
KOR activation by U50,488 showed signiﬁcant and robust poten-
tiation of reinstatement to cocaine seeking when compared to
mice that were not subjected to FSS but that were injected with
only U50,488 to induce reinstatement (Figure 1B, n = 8–15
(***p < 0.001, no stress and U50 vs. FSS and U50; one-way
ANOVA, Bonferroni post hoc test). Locomotor activity during
the reinstatement test was measured and the combination of
FSS, followed by KOR-induced reinstatement to cocaine seeking
showed a reduction in locomotor activity when compared to both
the non-stressed group and the FSS alone group (Figure 1C).
These data suggest that acute stress exposure induces a poten-
tiation of KOR agonist-induced reinstatement of cocaine place
preference.
SUB-CHRONIC STRESS EXPOSURE BLOCKS SUBSEQUENT KOR
AGONIST-INDUCED REINSTATEMENT OF COCAINE PLACE
PREFERENCE
To determine the effects of multiple rounds of stress exposure on
KOR-induced reinstatement, mice were subjected to 20 min of
SDS at the end of the day during extinction training and prior
to the reinstatement phase. On day 10, the reinstatement test
day, a single dose of U50,488 (5 mg/kg, i.p.) was administered
to induce reinstatement of cocaine place preference (Figure 2A).
Prior exposure to sub-chronic SDS resulted in a signiﬁcant block
of U50,488 induced reinstatement of cocaine place preference
(Figure 2B: *p < 0.05, no stress and U50,488 vs. SDS and U50,488,
**p < 0.01, SDS and U50,488 vs. SDS and cocaine; one-way
ANOVA followed by Bonferroni post hoc test, n = 12–16). This
inhibition of reinstatement was selective for activation of KOR
because a priming injection of cocaine (15 mg/kg, s.c.) still caused
signiﬁcant reinstatement of cocaine CPP following exposure to
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FIGURE 1 | Acute forced swim stress potentiates U50,488-induced
reinstatement of cocaine place preference. (A)Timeline of cocaine place
preference-reinstatement experimental paradigm. (B) Cocaine preference
scores (day 5), calculated as post-test minus pre-test on the cocaine-paired
side (condition) and U50,488-induced (5 mg/kg, i.p.) reinstatement scores
(day 10) of extinguished place preference (reinstate). Data show a signiﬁcant
potentiation in KOR-reinstatement following forced swim stress and U50,488.
Groups are deﬁned in the ﬁgures as their ﬁnal reinstatement grouping
(U50 = U50,488). Data represent the mean preference (s) ± SEM, n = 8–15
(***p < 0.001, no stress and U50 vs. forced swim stress and U50;
one-way ANOVA followed by Bonferroni post hoc test). (C) Locomotor
activity measured as distance traveled (cm) during the 30 min
reinstatement trial. Data represent the mean preference (s) ± SEM,
n = 8–15.
the sub-chronic SDS paradigm (Figure 2B; **p < 0.01, SDS
and U50 vs. SDS with cocaine, n = 12–16). We also measured
locomotor activity during the 30 min reinstatement phase. Both
the non-stress + U50,488 group and the SDS + U50,488 group
show a similar KOR-mediated reduction in locomotor over the
30 min period, supporting the notion that prevention of rein-
statement by pre-exposure to stress, is not due to additional
alterations in mouse locomotor activity (Figure 2C). In contrast,
as shown in previous studies (Reith, 1986; Tolliver et al., 1994;
Giros et al., 1996; Sora et al., 1998; Zhang et al., 2002) locomotor
activity was signiﬁcantly elevated in mice reinstated with cocaine
(##p < 0.01 and ###p < 0.005, SDS and U50,488 vs. SDS and
cocaine at 5 and 10 min time point, respectively; **p < 0.01, no
stress and U50,488 vs. SDS and U50,488 at 10 min time point;
***p < 0.005, SDS and cocaine vs. both no stress and U50 and
SDS and U50,488 at 15 min; ****p < 0.001 SDS and cocaine vs.
both no stress and U50 and SDS and U50,488 at 20, 25, and
30 min time points; two-way ANOVA followed by Bonferroni
post hoc test, n = 12–16). Taken together, these data suggest that
exposure to a sub-chronic repeated SDS causes a signiﬁcant pre-
vention of kappa agonist-induced reinstatement of cocaine place
preference.
CHRONIC MILD STRESS PROTECTS AGAINST U50,488-INDUCED
REINSTATEMENT TO COCAINE AND NICOTINE PLACE PREFERENCE
Kappa opioid receptor agonists and stress have been shown in
numerous models to affect the magnitude of cocaine and nicotine
place preference aswell as cause reinstatement of cocaine andnico-
tine preference behavior (Redila and Chavkin, 2008; Land et al.,
2009; Bruchas et al., 2010; Al-Hasani andBruchas, 2011; Al-Hasani
et al., 2013; Jackson et al., 2013). However, it is not known how
repeated CMS ultimately inﬂuences cocaine and nicotine prefer-
ence, or how CMS inﬂuences subsequent KOR or drug-primed
reinstatement of cocaine or nicotine reinstatement. Therefore, we
determined how a CMS paradigm adapted from Elizalde et al.
(2008); Peng et al. (2012), and Tye et al. (2013) (Table 1 and
Figures 3A and 4A) inﬂuences cocaine and nicotine condition-
ing, as well as KOR-induced reinstatement of cocaine and nicotine
CPP. The CMS paradigm involved a random assignment of seven
mild stressors during a 3-week period (see Table 1) prior to the
cocaine or nicotine CPP/reinstatement training protocol.
There was no signiﬁcant difference between the no stress and
CMS-exposed groups in the magnitude of the initial cocaine
(15 mg/kg, s.c.) or nicotine (0.5 mg/kg, s.c.) conditioned place
preference scores. This ﬁnding suggests that exposure to CMSdoes
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FIGURE 2 | Exposure to sub-chronic social defeat stress prevents
U50,488-induced reinstatement of cocaine place preference. (A)Timeline
of cocaine place preference-reinstatement experiment. (B) Cocaine
preference scores (day 5) calculated as post-test minus pre-test on the
cocaine-paired side (condition) and U50,488-induced (5 mg/kg, i.p.)
reinstatement scores (day 10) of extinguished place preference (reinstate),
calculated as reinstatement test day minus extinction post-test day.
Groups are deﬁned in the ﬁgures as their ﬁnal reinstatement grouping
(U50 = U50,488). Data show a signiﬁcant attenuation in KOR-reinstatement
following sub-chronic social defeat stress. Data represent the mean
preference (s) ± SEM, n = 12–16 (*p < 0.05, no stress and U50,488 vs.
social defeat stress and U50,488, **p < 0.01, social defeat stress and
U50,488 vs. social defeat stress and cocaine; one-way ANOVA followed by
Bonferroni post hoc test). (C) Locomotor activity measured as distance
traveled (cm) during the 30 min reinstatement trial. Data represent the mean
preference (s) ± SEM, n = 12–16 (##p < 0.01 and ###p < 0.005, social defeat
stress and U50,488 vs. social defeat stress and cocaine at 5 and 10 min
time point, respectively; **p < 0.01, no stress and U50,488 vs. social
defeat stress and U50,488 at 10 min time point; ***p < 0.005, social
defeat stress and cocaine vs. both no stress and U50 and social defeat
stress and U50,488 at 15 min; ****p < 0.001 social defeat stress and
cocaine vs. both no stress and U50 and social defeat stress and U50,488
at 20, 25, and 30 min time points; two-way ANOVA followed by Bonferroni
post hoc test).
not effect the subsequent conditioned rewarding effects of cocaine
or nicotine (Figures 3B and 4B). Extinction rates of place pref-
erence between no stress, SDS-exposed and CMS-exposed groups
were not signiﬁcantly changed. In contrast, following extinction
of either cocaine or nicotine place preference in CMS groups,
KOR-induced reinstatement of both cocaine and nicotine place
preference was signiﬁcantly reduced (Figure 3B: *p < 0.05, no
stress and U50,488 vs. stress and U50,488; Student’s t-test, n = 7;
Table 1 |Three-week chronic mild stress schedule.
Week Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
1 17:00 to next day:
damp bedding
4 h white noise 8 h cage tilt Continuous light
24 h
Removal of
nesting 24 h
Food and water
deprivation 8 h
Swimming at 4◦C
for 5 min
2 Continuous light
24 h
17:00 to next day:
damp bedding
Food and water
deprivation 8 h
Swimming at 4◦C
for 5 min
8 h cage tilt 4 h white noise Removal of nest-
ing 24 h
3 Swimming at 4◦C
for 5 min
Continuous light
24 h
8 h cage tilt Removal of
nesting 24 h
4 h white noise Food and water
deprivation 8 h
17:00 to next day:
damp bedding
Three weeks prior to cocaine or nicotine conditioned place preference-reinstatement paradigm the mice were randomly assigned the different stressors
highlighted in the table. Paradigm is modiﬁed from Elizalde et al. (2008); Peng et al. (2012), andTye et al. (2013).
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FIGURE 3 | Exposure to chronic mild stress blocks U50,488-induced
but not cocaine-primed reinstatement of cocaine place preference.
(A)Timeline of cocaine place preference-reinstatement experiment. (B) Cocaine
preference scores (day 26), calculated as post-test minus pre-test on the
cocaine-paired side (condition), U50,488-induced (5 mg/kg, i.p.) reinstatement
scores (reinstate, day 31), or cocaine-induced (15 mg/kg, i.p) reinstatement
(prime, day 32) of extinguished place preference. Data show a signiﬁcant
attenuation in U50,488-induced but not cocaine-primed reinstatement to
cocaine seeking following chronic mild stress. Groups are deﬁned in the
ﬁgures as their ﬁnal reinstatement grouping (U50 = U50,488).Data represent
the mean preference (s) ± SEM, n = 7 (*p < 0.05, no stress and U50,488 vs.
stress and U50,488; Unpaired Student’s t -test). (C) Locomotor activity
measured as distance traveled (cm) during three cocaine conditioning days.
Data represent the mean preference (s) ± SEM, n = 7 (#p < 0.05 day 23 vs.
day 25 in the no stress group; **p < 0.01day 23 vs. day 24 and ***p < 0.005
day 23 vs. day 25 between stress group; one-way ANOVA followed by
Bonferroni post hoc test). (D) Locomotor activity measured as distance
traveled (cm) during reinstatement. Data represent the mean preference
(s) ± SEM, n = 7 (*p < 0.05 at 5 min time point in the no stress group vs.
CMS group; two-way ANOVA followed by Bonferroni post hoc test).
Figure 4B: *p < 0.05, Student’s t-test, n = 5–8. While CMS pro-
tected againstU50,488-induced reinstatement it had no signiﬁcant
effect on cocaine or nicotine drug-primed reinstatement; indi-
cating that this protective effect of CMS was selective for KOR
agonist-induced reinstatement. Locomotor activity was measured
during the 3-day conditioning period to determine if exposure
to 3 weeks of CMS alters the locomotor response to nicotine
(0.05 mg/kg, s.c.) and cocaine (15 mg/kg, s.c.). No signiﬁcant dif-
ferences in locomotor activity were found between no stress group
and the CMS group following cocaine treatment (Figure 3C). As
predicted, distance traveled signiﬁcantly increased over the 3-day
cocaine conditioning period, as previously shown (Zhang et al.,
2002; Tzschentke, 2007; Figure 3C: #p < 0.05 day 23 vs. day 25 in
the no stress group; **p < 0.01 day 23 vs. day 24 and ***p < 0.005
day 23 vs. day 25 between stress group; one-way ANOVA followed
by Bonferroni post hoc test, n = 7). However, nicotine-induced
elevations in locomotor activity were signiﬁcantly reduced follow-
ing CMS on the second and third day of nicotine conditioning
(Figure 4C: *p < 0.05, no stress vs. CMS as compared to the
no-CMS group; two-way ANOVA followed by Bonferroni post hoc
test, n = 5–8). Locomotor activity was also measured during U50-
induced reinstatement in both the nicotine and cocaine groups.
In the cocaine group only at the 5 min time point was there
a signiﬁcant decrease in locomotor activity in the CMS group
compared to the no stress group (Figure 3D: *p < 0.05; two-
way ANOVA followed by Bonferroni post hoc test). The nicotine
group showed a similar proﬁle, locomotor activity was also sig-
niﬁcantly decreased in the CMS group compared to the no stress
group at both the 5 and 10 min time point (Figure 4D: *p < 0.05;
two-way ANOVA followed by Bonferroni post hoc test). Together,
these results support the conclusion that CMS protects against
subsequent KOR-mediated cocaine and nicotine reinstatement
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FIGURE 4 | Exposure to chronic mild stress blocks U50,488-induced
but not nicotine-primed reinstatement of nicotine place preference.
(A)Timeline of nicotine place preference-reinstatement experiment.
(B) Nicotine preference scores (day 26), calculated as post-test minus pre-test
on the nicotine-paired side(condition), U50,488-induced (5 mg/kg, i.p.;
reinstate, day 31) and nicotine-induced (0.5mg/kg, i.p) reinstatement (prime,
day 32) scores of extinguished place preference. Data show a signiﬁcant
reinstatement of nicotine place preference following U50,488 in the no stress
group. Groups are deﬁned in the ﬁgures as their ﬁnal reinstatement grouping
(U50 = U50,488). Data represent the mean preference (s) ± SEM, n = 5–8
(*p < 0.05, Student’s t -test). (C) Locomotor activity measured as distance
traveled (cm) during three cocaine conditioning days. Data represent the
mean preference (s) ± SEM, n = 5–8 (*p < 0.05, no stress vs. chronic mild
stress on days 24 and 25, respectively; two-way ANOVA followed by
Bonferroni post hoc test). (D) Locomotor activity measured as distance
traveled (cm) during reinstatement. Data represent the mean preference
(s) ± SEM, n = 5–8 (*p < 0.05 at 5 min and 10 min time point in the no stress
group vs. CMS group; two-way ANOVA followed by Bonferroni post hoc test).
and further suggests that CMS may act to regulate KOR system
function.
DISCUSSION
In the present study we investigated the interactions between
various types of stress paradigms and how they inﬂuence KOR-
induced reinstatement of cocaine and nicotine preference. We
determined the effects of a single acute stress, sub-chronic
social defeat, and CMS on cocaine and nicotine conditioned
place preference and KOR-induced reinstatement. Although, FSS,
SDS, and CMS have all been implicated in regulating hedo-
nic state and reward, the present report describes a previously
unknown connection between prior stress exposure and KOR-
mediated stress-induced behavior. Together, these ﬁndings sug-
gest that various types of stress exposure act to inﬂuence the
dynorphin/KOR-mediated reinstatement response, but they also
demonstrate that prior CMS has no lasting effect on the rewarding
properties of cocaine or nicotine in conditioned place preference
paradigms.
Stress-induced opioid peptide release has been reported for
three major opioid systems, and its release has been demonstrated
to be associated with a variety of behavioral outputs including
stress-induced analgesia, reinstatement, dysphoria, depression,
and anxiety-like behaviors (Carlezon et al., 2006; Land et al.,
2008; Bruchas et al., 2010; Chartoff et al., 2012; Al-Hasani et al.,
2013). In these reports, animals are typically exposed to a sin-
gle stress event (e.g., forced swim, social defeat, foot shock)
and then KOR-mediated behaviors are measured following acute
stress exposure (McLaughlin et al., 2003; Bruchas et al., 2011;
Schindler et al., 2012). However, the stress experience over the
course of an animal’s lifetime is complex in nature occurring
usually in multiple, randomized epochs. Therefore, the effects
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of CMS on KOR-mediated behavior remain an important area
of investigation. Both repeated stress, and CMS models have
been reported to induce dramatic changes in neural circuits and
neuromodulator function (Hill et al., 2012; Lemos et al., 2012a,b;
Tye et al., 2013), however, CMS effects on regulating cocaine-,
nicotine-, and opioid-mediated conditioned preference behaviors
is not known. Speciﬁcally, CMS-induced changes in serotoner-
gic, noradrenergic, and dopaminergic signaling and release have
all been reported (Rasheed et al., 2008; Vancassel et al., 2008;
Hill et al., 2012) implicating important functions of monoamine
regulation in CMS alterations of mood and reward seeking.
In addition, it has been shown that repeated stress and CMS
dramatically alter neuropeptidergic circuit function and impact
neuropeptide modulation in subsequent stress responsivity, by
either sensitizing the response or acting to facilitate desensitiza-
tion. In the current report we found that following a single acute
FSS, activation of KOR signaling caused potentiation of cocaine
preference-reinstatement (Figure 1). In contrast, repeated SDS or
CMS protected against subsequent KOR-mediated reinstatement
(Figures 2, 3, and 4). We also found that this CMS protective
effect not only inﬂuenced KOR-induced cocaine reinstatement
(Figure 3) but it also blocked KOR-induced reinstatement of
nicotine place preference (Figure 4), suggesting a conservedmech-
anism for multiple drugs of abuse. Interestingly, CMS exposure
had no effect on the initial cocaine or nicotine conditioning, nor
did CMS exposure impact the magnitude of drug-primed rein-
statement. These ﬁndings suggest that SDS and CMS induce a
type of “tolerance” to subsequent KOR activity, which has also
been previously reported when administering repeated doses of
KOR agonists (McLaughlin et al., 2004). Stress adaptability mech-
anisms are a critical consideration in our current ﬁndings because
reports demonstrating that dramatic changes in neural circuit
function include effects on KOR and corticotropin releasing fac-
tor (CRF) signaling following various types of repeated stress
exposure (McEwen and Gianaros, 2011; Lemos et al., 2012a,b).
The precise neuronal and molecular mechanisms for SDS- and
CMS-induced attenuation of KOR-induced reinstatement were
not identiﬁed in this study but are important and exciting exten-
sions of this work. There are a number of mechanisms that maybe
involved in CMS-induced regulation of KOR-reinstatement. KOR
regulation following repeated and high agonist-receptor occu-
pancy has been previously reported to be mediated by GRK3
phosphorylation of serine 369 in mouse/rat KOR or serine 358
in the human KOR (Wang et al., 2003; McLaughlin et al., 2004;
Bruchas et al., 2006, 2007a; Chen et al., 2007). In repeated SDS
or CMS models it is possible that recurrent activation of KOR
causes subsequent downregulation and desensitization of KOR
signaling preventing further activation of KOR until full recov-
ery. Furthermore, KOR regulation and deactivation (in contrast to
mu-opioid receptors) take several weeks to recover as functional
receptor entities (McLaughlin et al., 2004; Bruchas et al., 2007b),
consistent with the CMS time course used in this study. Sur-
prisingly the preventative effect of prior stress on KOR-mediated
reinstatement did not also preventKOR-induceddecreases in loco-
motor activity (Figure 2C) suggesting that SDS acts in speciﬁc
neural circuits associated with reinstatement but not locomotion.
Therefore selective blockade of KORs in speciﬁc brain regions
during repeated SDS, and CMS and subsequent measures of
KOR-mediated behavioral responses will be required in future
studies. In addition, utilizing GRK3 knockout mice, or expression
of KOR-S369/358 mutants in vivo, and exposure to CMS are inter-
esting extensions of this work as prior work has shown that GRK3
signaling is required for KOR-mediated behavioral effects via
phosphorylation, arrestin recruitment, andp38 signaling (Bruchas
et al., 2011). It has also been shown that KOR-mediated signaling
to G-protein inwardly rectifying potassium channels in the sero-
tonergic dorsal raphe nucleus (DRN) is altered following repeated
stress exposure (Lemos et al., 2012a). Together, with the recent
evidence that these circuits are implicated in KOR-induced rein-
statement (Land et al., 2009; Bruchas et al., 2011) it is possible that
CMS causes dysregulation of KOR signaling in the DRN to ulti-
mately inﬂuence subsequent KOR-induced behavioral responses
including reinstatement of drug seeking. Furthermore, CMS may
cause downregulation of KOR in the locus coeruleus, a region
which has recently been identiﬁed to play a key role in KOR-
mediated reinstatement to cocaine place preference (Al-Hasani
et al., 2013). However, these hypotheses will require further study
using selective neural circuit dissection techniques.
The effects of stress on cocaine and nicotine seeking have been
widely reported by numerous groups (for reviews see Koob, 2008;
Aguilar et al., 2009). In the case of cocaine, it is well-established
that stress and exposure to cues causes robust reinstatement
of drug seeking in both animals models and human subjects
(Koob and Kreek, 2007). The effects of stress on nicotine rein-
statement in animal models are less well-characterized, although
reports have shown that acute stress exposure potentiates nicotine-
seeking behavior and reinstates drug seeking (Buczek et al., 1999;
Bilkei-Gorzo et al., 2008; Plaza-Zabala et al., 2010; Yamada and
Bruijnzeel, 2011; Leão et al., 2012; Smith et al., 2012). It has also
been established that human subjects widely report stress as the
primary reason for their continued tobacco use (Bruijnzeel, 2012).
However, the effects of randomized CMS on nicotine place prefer-
ence in animal models has not been previously studied, nor have
mechanisms of stress on KOR-induced regulation of nicotine-
induced behavior been widely explored with the exception of
some recent reports implicating KOR in nicotine-induced behav-
ior (Smith et al., 2012; Jackson et al., 2013). Our current ﬁndings
build on this prior work, and for the ﬁrst time show that agonist-
induced KOR activation is sufﬁcient to cause reinstatement of
nicotine CPP. Additionally, our ﬁnding that KOR agonist does not
promote reinstatement of nicotine CPP following CMS suggests
interesting and complex interactions between CMS and dynor-
phin/KOR neural circuits that are conserved for both nicotine and
cocaine. However, whether similar neural circuits (e.g., dopamin-
ergic, serotonergic) are required for KOR-dependent nicotine
reinstatement as compared to cocaine reinstatement will require
further investigation.
In summary, we report that frequency and duration of stress
differentially inﬂuences KOR-induced reinstatement of cocaine
and nicotine preference. The present study shows that repeated
stress or CMS prior to reinstatement prevents a KOR-induced
reinstatement response, while acute exposure to stress induces
potentiation of KOR-reinstatement. The wide array of recent
studies investigating the interactions between stress and KOR
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function on reward, reinstatement, and dysphoria suggest that
KOR interacts withmultiple neurotransmitter systems and circuits
to mediate its complex role in behavioral output. We identiﬁed
previously unrecognized roles for acute, sub-chronic, and chronic
stress exposure onKOR-mediatedbehavioral function. Theseﬁnd-
ings suggest that understanding the regulation of dynorphin/KOR
systems in response to various stress exposures is critical to under-
standing and identifying KOR as a potentially novel therapeutic
target system in drug relapse, anxiety, and depression.
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